Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L21 pseudogene 38 (RPL21P38) is a human processed pseudogene related to the ribosomal protein L21 gene. Pseudogenes like RPL21P38, by definition, are DNA sequences similar to normal genes but are non-functional; they arise from the duplication or retrotransposition of functional genes but have lost their ability to encode a protein due to mutations, truncations, or absence of regulatory elements. RPL21P38 has no known function, is not expressed as a protein, and has not been associated with disease or drug targeting. The functional version of this gene family, ribosomal protein L21 (RPL21), is a component of the large 60S subunit of the ribosome and is involved in protein synthesis, but RPL21P38 itself serves no known cellular or therapeutic role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L21 pseudogene 38 (RPL21P38).